Adaptive radiation therapy for intermediate- or high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a type of radiation that adjusts to changes in your prostate during treatment. It aims to improve accuracy and reduce side effects for men with intermediate- or high-risk prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have intermediate- or favorable high-risk prostate cancer that has not spread outside the prostate.
- You are over 18 years old and in reasonably good health (able to care for yourself).
- You had a special MRI or PSMA PET scan showing a suspicious area within the last year.
- Your prostate is not too large (less than about 100 cc on MRI or ultrasound).
- You have not had radiation therapy to the pelvic area before.
- You are not currently taking other cancer treatments or experimental drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This study tests a new combination of radiation (SBRT) and short-term hormone therapy (6 months) to see how it affects sexual function in men with unfavorable intermediate-risk prostate cancer.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.